Development of β-Lapachone prodrugs for therapy against human cancer cells with elevated NAD(P)H:quinone oxidoreductase 1 levels

por Reinicke, K.E., Bey, E.A., Bentle, M.S., Pink, J.J., Ingalls, S.T., Hoppel, C.L., Misico, R.I., Arzac, G.M., Burton, G., Bornmann, W.G., Sutton, D., Gao, J., Boothman, D.A.
Publicado 2005

Development of β-Lapachone prodrugs for therapy against human cancer cells with elevated NAD(P)H:quinone oxidoreductase 1 levels

por Reinicke, K.E., Bey, E.A., Bentle, M.S., Pink, J.J., Ingalls, S.T., Hoppel, C.L., Misico, R.I., Arzac, G.M., Burton, G., Bornmann, W.G., Sutton, D., Gao, J., Boothman, D.A.

Development of β-Lapachone prodrugs for therapy against human cancer cells with elevated NAD(P)H:quinone oxidoreductase 1 levels

por Reinicke, K.E., Bey, E.A., Bentle, M.S., Pink, J.J., Ingalls, S.T., Hoppel, C.L., Misico, R.I., Arzac, G.M., Burton, G., Bornmann, W.G., Sutton, D., Gao, J., Boothman, D.A.
Publicado 2005